Search

The author focuses on the performance of administrative drug-scheduling processes in dealing with drugs examined by C. Coulson and J. P. Caulkins. The author mentions that four possible Type II errors were discovered by the researchers and found that legislative action is responsible for one probable Type I error. He adds that the single class of benefit from the use of any drug recognized in the conventions and the Controlled Substances Act was noted by the researchers.